FOLD Deferred Revenue
Amicus Therapeutics Inc · Deferred Revenue
FOLD Deferred Revenue
Latest reported$0.00period ending
FOLD Quarterly Deferred Revenue ($0.00 → $0.00)
Quarterly deferred revenue
High-resolution chart · PNG
FOLD deferred revenue history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 97,506,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -21,022,000 | |
| -10,471,000 | |
| -13,824,000 | |
| -11,171,000 | |
| -9,366,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| -6,730,000 | |
| -9,428,000 | |
| 7,929,000 | |
| 8,187,000 | |
| 8,504,000 | |
| 9,274,000 | |
| 8,606,000 | |
| 7,965,000 | |
| 6,640,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 2,778,000 | |
| 2,778,000 | |
| 3,176,000 | |
| 3,705,000 | |
| 4,043,000 | |
| 3,295,000 | |
| 4,612,000 | |
| 3,801,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |